This MD PE ratio history page last updated 4/23/2024
Period | Price | Adj. EPS | TTM | PE |
Q4 2023 2/20/2024 | 8.46 | 0.32 | 1.26 | 6.7 | Q3 2023 11/2/2023 | 9.89 | 0.32 | 1.41 | 7.0 | Q2 2023 8/3/2023 | 14.73 | 0.39 | 1.49 | 9.9 | Q1 2023 5/2/2023 | 14.74 | 0.23 | 1.57 | 9.4 | Q4 2022 2/17/2023 | 16.71 | 0.47 | 1.67 | 10.0 | Q3 2022 11/3/2022 | 15.18 | 0.40 | 1.72 | 8.8 | Q2 2022 8/4/2022 | 19.36 | 0.47 | 1.78 | 10.9 | Q1 2022 4/28/2022 | 20.69 | 0.33 | 1.72 | 12.0 | Q4 2021 2/17/2022 | 24.18 | 0.52 | 1.63 | 14.8 | Q3 2021 10/28/2021 | 27.77 | 0.46 | 1.36 | 20.4 | Q2 2021 8/6/2021 | 33.14 | 0.41 | 1.27 | 26.1 | Q1 2021 5/7/2021 | 32.10 | 0.24 | 1.18 | 27.2 | Q4 2020 2/18/2021 | 20.82 | 0.25 | 1.26 | 16.5 | Q3 2020 11/6/2020 | 16.50 | 0.37 | 1.92 | 8.6 | Q2 2020 7/30/2020 | 20.39 | 0.32 | 2.46 | 8.3 | Q1 2020 5/7/2020 | 13.10 | 0.32 | 3.03 | 4.3 | Q4 2019 2/20/2020 | 20.96 | 0.91 | 3.36 | 6.2 | Q3 2019 11/1/2019 | 24.46 | 0.91 | 3.37 | 7.3 | Q2 2019 8/1/2019 | 22.21 | 0.89 | 3.40 | 6.5 | Q1 2019 5/2/2019 | 28.55 | 0.65 | 3.58 | 8.0 | Q4 2018 2/7/2019 | 36.32 | 0.92 | 3.82 | 9.5 | Q3 2018 11/1/2018 | 38.63 | 0.94 | 3.77 | 10.2 | Q2 2018 8/2/2018 | 45.12 | 1.07 | 3.70 | 12.2 | Q1 2018 4/30/2018 | 45.91 | 0.89 | 3.48 | 13.2 | Q4 2017 2/8/2018 | 52.56 | 0.87 | 3.34 | 15.7 | Q3 2017 11/1/2017 | 41.35 | 0.87 | 3.47 | 11.9 | Q2 2017 7/28/2017 | 47.73 | 0.85 | 3.69 | 12.9 | Q1 2017 5/4/2017 | 56.05 | 0.75 | 3.87 | 14.5 | Q4 2016 2/7/2017 | 65.25 | 1.00 | 3.99 | 16.4 | Q3 2016 10/27/2016 | 60.90 | 1.09 | 4.12 | 14.8 | Q2 2016 7/28/2016 | 69.93 | 1.03 | 4.13 | 16.9 | Q1 2016 4/28/2016 | 70.75 | 0.87 | 4.12 | 17.2 | Q4 2015 2/4/2016 | 63.93 | 1.13 | 3.97 | 16.1 | Q3 2015 10/29/2015 | 71.25 | 1.10 | 3.73 | 19.1 | Q2 2015 7/30/2015 | 82.01 | 1.02 | 3.49 | 23.5 | Q1 2015 4/30/2015 | 70.78 | 0.72 | 3.26 | 21.7 | Q4 2014 1/29/2015 | 68.84 | 0.89 | 3.17 | 21.7 | Q3 2014 10/30/2014 | 61.50 | 0.86 | 3.06 | 20.1 | Q2 2014 7/31/2014 | 59.18 | 0.79 | 2.96 | 20.0 | Q1 2014 5/1/2014 | 58.37 | 0.63 | 2.86 | 20.4 | Q4 2013 1/30/2014 | 54.70 | 0.78 | 2.78 | 19.7 | Q3 2013 10/31/2013 | 54.51 | 0.76 | 2.66 | 20.5 | Q2 2013 7/30/2013 | 48.71 | 0.69 | 2.56 | 19.0 | Q1 2013 5/2/2013 | 44.91 | 0.55 | 2.48 | 18.1 | Q4 2012 1/31/2013 | 42.78 | 0.66 | 2.18 | 19.6 | Q3 2012 11/1/2012 | 36.71 | 0.66 | NA | NA | Q2 2012 7/31/2012 | 33.07 | 0.61 | NA | NA | Q1 2012 5/3/2012 | 33.60 | 0.25 | NA | NA |
|
Period | Price | Adj. EPS | Annualized | PE |
Q4 2023 2/20/2024 | 8.46 | 0.32 | 1.28 | 6.6 | Q3 2023 11/2/2023 | 9.89 | 0.32 | 1.28 | 7.7 | Q2 2023 8/3/2023 | 14.73 | 0.39 | 1.56 | 9.4 | Q1 2023 5/2/2023 | 14.74 | 0.23 | 0.92 | 16.0 | Q4 2022 2/17/2023 | 16.71 | 0.47 | 1.88 | 8.9 | Q3 2022 11/3/2022 | 15.18 | 0.40 | 1.60 | 9.5 | Q2 2022 8/4/2022 | 19.36 | 0.47 | 1.88 | 10.3 | Q1 2022 4/28/2022 | 20.69 | 0.33 | 1.32 | 15.7 | Q4 2021 2/17/2022 | 24.18 | 0.52 | 2.08 | 11.6 | Q3 2021 10/28/2021 | 27.77 | 0.46 | 1.84 | 15.1 | Q2 2021 8/6/2021 | 33.14 | 0.41 | 1.64 | 20.2 | Q1 2021 5/7/2021 | 32.10 | 0.24 | 0.96 | 33.4 | Q4 2020 2/18/2021 | 20.82 | 0.25 | 1.00 | 20.8 | Q3 2020 11/6/2020 | 16.50 | 0.37 | 1.48 | 11.1 | Q2 2020 7/30/2020 | 20.39 | 0.32 | 1.28 | 15.9 | Q1 2020 5/7/2020 | 13.10 | 0.32 | 1.28 | 10.2 | Q4 2019 2/20/2020 | 20.96 | 0.91 | 3.64 | 5.8 | Q3 2019 11/1/2019 | 24.46 | 0.91 | 3.64 | 6.7 | Q2 2019 8/1/2019 | 22.21 | 0.89 | 3.56 | 6.2 | Q1 2019 5/2/2019 | 28.55 | 0.65 | 2.60 | 11.0 | Q4 2018 2/7/2019 | 36.32 | 0.92 | 3.68 | 9.9 | Q3 2018 11/1/2018 | 38.63 | 0.94 | 3.76 | 10.3 | Q2 2018 8/2/2018 | 45.12 | 1.07 | 4.28 | 10.5 | Q1 2018 4/30/2018 | 45.91 | 0.89 | 3.56 | 12.9 | Q4 2017 2/8/2018 | 52.56 | 0.87 | 3.48 | 15.1 | Q3 2017 11/1/2017 | 41.35 | 0.87 | 3.48 | 11.9 | Q2 2017 7/28/2017 | 47.73 | 0.85 | 3.40 | 14.0 | Q1 2017 5/4/2017 | 56.05 | 0.75 | 3.00 | 18.7 | Q4 2016 2/7/2017 | 65.25 | 1.00 | 4.00 | 16.3 | Q3 2016 10/27/2016 | 60.90 | 1.09 | 4.36 | 14.0 | Q2 2016 7/28/2016 | 69.93 | 1.03 | 4.12 | 17.0 | Q1 2016 4/28/2016 | 70.75 | 0.87 | 3.48 | 20.3 | Q4 2015 2/4/2016 | 63.93 | 1.13 | 4.52 | 14.1 | Q3 2015 10/29/2015 | 71.25 | 1.10 | 4.40 | 16.2 | Q2 2015 7/30/2015 | 82.01 | 1.02 | 4.08 | 20.1 | Q1 2015 4/30/2015 | 70.78 | 0.72 | 2.88 | 24.6 | Q4 2014 1/29/2015 | 68.84 | 0.89 | 3.56 | 19.3 | Q3 2014 10/30/2014 | 61.50 | 0.86 | 3.44 | 17.9 | Q2 2014 7/31/2014 | 59.18 | 0.79 | 3.16 | 18.7 | Q1 2014 5/1/2014 | 58.37 | 0.63 | 2.52 | 23.2 | Q4 2013 1/30/2014 | 54.70 | 0.78 | 3.12 | 17.5 | Q3 2013 10/31/2013 | 54.51 | 0.76 | 3.04 | 17.9 | Q2 2013 7/30/2013 | 48.71 | 0.69 | 2.76 | 17.6 | Q1 2013 5/2/2013 | 44.91 | 0.55 | 2.20 | 20.4 | Q4 2012 1/31/2013 | 42.78 | 0.66 | 2.64 | 16.2 | Q3 2012 11/1/2012 | 36.71 | 0.66 | 2.64 | 13.9 | Q2 2012 7/31/2012 | 33.07 | 0.61 | 2.44 | 13.6 | Q1 2012 5/3/2012 | 33.60 | 0.25 | 1.00 | 33.6 |
|
On this page we presented the MD PE Ratio History information for Pediatrix Medical Group' stock.
The average MD PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 15.2. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average MD PE ratio history based on this TTM earnings result method is 14.5.
Let's now compare this MD PE ratio history result, against the recent PE: when this page was posted on 4/22/2024, the most recent closing price for MD had been 9.03, and the most recent quarterly earnings result, annualized, was 1.28. Meanwhile, the most recent TTM earnings summed to 1.26. From these numbers, we calculate the recent MD PE on 4/22/2024 based on annualized quarterly EPS was 7.1. Based on MD's history, that recent PE is low relative to the historical average, with the recent PE 53.3% lower than the historical average PE across our data set for Pediatrix Medical Group. Looking at the recent MD PE on 4/22/2024 based on TTM EPS, we calculate the ratio at 7.2. Based on MD's history, that recent PE is low relative to the historical average, with the recent PE 50.3% lower than the average PE across our Pediatrix Medical Group data set with TTM EPS used in the calculation at each period.
Another interesting MD PE ratio history calculation we look at is to take the median earnings per share of the last four quarters for MD, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for MD, we start with the past four EPS numbers and we first sort them from lowest to highest: 0.23, 0.32, 0.32, and 0.39. We then toss out the highest and lowest result, and then take the average of those two middle numbers — 0.32 and 0.32 — which gives us the median of 0.32. Basically the way to think about this 0.32 number is this: for the trailing four earnings reports, 0.32 marks the "middle ground" number where MD has reported a value higher than 0.32 half the time, and has reported a value lower than 0.32 half the time. Annualizing that median value then gets us to 1.28/share, which we use as the denominator in our next PE calculation. With 9.03 as the numerator (as of 4/22/2024), the calculation is then 9.03 / 1.28 = 7.1 as the MD PE ratio as of 4/22/2024, based on that annualized median value we calculated.
For self directed investors doing their due diligence on MD or any other given stock, valuation analysis for MD
can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can
help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios
justify the current stock market value.
That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate
Pediatrix Medical Group PE ratio history — or the PE history for any stock in our coverage universe.
And in your continued research we hope you will be sure to check out the further links included for
next earnings dates and also historical earnings surprises history for MD. Thanks for visiting, and the next
time you need to research MD PE Ratio History or the PE ratio history for another stock, we hope our site
will come to mind as your go-to PE ratio history research resource of choice.